In this study, TMA data demonstrated that a high proportion (89.4%) of cervical cancer cases exhibited a high expression level of UBE2C protein (Supplementary Table S1), which was supported by the gene profiling assay of UBE2C gene expression in cervical cancer tissue [30,31]. The gene discussed is UBE2C; the disease is cervical carcinoma.